Cargando…

Prognostic value of interleukin-6 and interleukin-6 receptor in organ-confined clear-cell renal cell carcinoma: a 5-year conditional cancer-specific survival analysis

BACKGROUND: Interleukin-6 (IL-6) is the major cytokine that induces transcriptional acute and chronic inflammation responses, and was recently incorporated as a recurrence prognostication signature for localised clear-cell renal cell carcinoma (ccRCC). As the prognostic efficacy of initial risk fact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Qiang, Chang, Yuan, An, Huimin, Fu, Hangcheng, Zhu, Yu, Xu, Le, Zhang, Weijuan, Xu, Jiejie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705889/ https://www.ncbi.nlm.nih.gov/pubmed/26554658 http://dx.doi.org/10.1038/bjc.2015.379

Ejemplares similares

Interleukin-6 gene amplification and shortened survival in glioblastoma patients
por: Tchirkov, A, et al.
Publicado: (2007)

Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour–stroma interaction
por: Nagasaki, T, et al.
Publicado: (2014)

The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer
por: Ramsey, S, et al.
Publicado: (2006)

Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells
por: Terakawa, T, et al.
Publicado: (2009)

High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma
por: Pan, Deng, et al.
Publicado: (2015)

Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients
por: Aubele, M, et al.
Publicado: (2008)

Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to KRAS mutation in lung adenocarcinoma
por: Sunaga, N, et al.
Publicado: (2014)

High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma
por: An, H, et al.
Publicado: (2014)

Relative prognostic value of TNM7 vs TNM6 in staging oesophageal cancer
por: Reid, T D, et al.
Publicado: (2011)

Prognostic value of granulocyte colony-stimulating factor in patients with non-metastatic clear cell renal cell carcinoma
por: Liu, Zheng, et al.
Publicado: (2017)

Expression and prognostic significance of Src family members in renal clear cell carcinoma
por: Qayyum, T, et al.
Publicado: (2012)

Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions
por: Prokopchuk, O, et al.
Publicado: (2005)

Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil–lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma
por: Dalpiaz, Orietta, et al.
Publicado: (2017)

A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures
por: Sandanayake, N S, et al.
Publicado: (2011)

Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma
por: Saroufim, A, et al.
Publicado: (2014)

A three-molecule score based on Notch pathway predicts poor prognosis in non-metastasis clear cell renal cell carcinoma
por: Liu, Zheng, et al.
Publicado: (2016)

Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma
por: Chang, Y, et al.
Publicado: (2015)

Low Expression of Mucin-4 Predicts Poor Prognosis in Patients With Clear-Cell Renal Cell Carcinoma
por: Fu, Hangcheng, et al.
Publicado: (2016)

High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma
por: Wang, Hua, et al.
Publicado: (2016)

Interleukin-1α is the major alarmin of lung epithelial cells released during photodynamic therapy to induce inflammatory mediators in fibroblasts
por: Tracy, E C, et al.
Publicado: (2012)

Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis
por: Srivastava, S K, et al.
Publicado: (2015)

Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis
por: White, N M A, et al.
Publicado: (2014)

Differential expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4 during uterine cervix carcinogenesis: diagnostic and prognostic value
por: Lomnytska, M I, et al.
Publicado: (2011)

CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2
por: Bedognetti, D, et al.
Publicado: (2013)

Annexin II represents metastatic potential in clear-cell renal cell carcinoma
por: Ohno, Y, et al.
Publicado: (2009)

Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis
por: Lee, Y S, et al.
Publicado: (2012)

Elevated tumour interleukin-1β is associated with systemic inflammation: a marker of reduced survival in gastro-oesophageal cancer
por: Deans, D A C, et al.
Publicado: (2006)

Prognostic value of microRNA expression in operable non-small cell lung cancer patients
por: Skrzypski, M, et al.
Publicado: (2014)

Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastases
por: Lalmahomed, Z S, et al.
Publicado: (2015)

Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma
por: Rückert, F, et al.
Publicado: (2008)

Identification of high-risk patients with clear cell renal cell carcinoma based on interphase-FISH
por: Sanjmyatav, J, et al.
Publicado: (2014)

Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma
por: Xie, Huyang, et al.
Publicado: (2016)

Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma
por: Choi, Y, et al.
Publicado: (2013)

Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma
por: Kinoshita, A, et al.
Publicado: (2012)

Decreased Expression of SETD2 Predicts Unfavorable Prognosis in Patients With Nonmetastatic Clear-Cell Renal Cell Carcinoma
por: Liu, Weisi, et al.
Publicado: (2015)

The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer
por: Al-Saad, S, et al.
Publicado: (2008)

Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery
por: El-Mokadem, I, et al.
Publicado: (2014)

MicroRNA profiling in clear cell renal cell carcinoma tissues potentially links tumorigenesis and recurrence with obesity
por: Shu, X, et al.
Publicado: (2017)

Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival
por: Li, Z, et al.
Publicado: (2011)

Role of Interleukin-6 in Vascular Health and Disease
por: Villar-Fincheira, Paulina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kt1drlb8176iefqloq4rc1gboa